Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method
Background and purpose: Immunoadsorption (IA) is an antibody-depleting therapy used to treat neuromyelitis optica spectrum disorder (NMOSD) associated to antiaquaporin 4 (anti-AQP4-IgG) and antimyelin oligodendrocyte glycoprotein (anti-MOG-IgG) serum autoantibodies. Our aim was to evaluate longitudi...
Main Authors: | Luca Bollo, Pietro Iaffaldano, Maddalena Ruggieri, Claudia Palazzo, Mariangela Mastrapasqua, Alessia Manni, Damiano Paolicelli, Antonio Frigeri, Maria Trojano |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2021.633115/full |
Similar Items
-
Drug Treatment of Neuromyelitis Optica Spectrum Disorders: Out with the Old, in with the New?
by: Held F, et al.
Published: (2021-03-01) -
Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD
by: Giulia Fadda, et al.
Published: (2022-11-01) -
Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel
by: Livnat Brill, et al.
Published: (2021-01-01) -
Seroprevalence of NMO-IgG antibody in Brazilian patients with neuromyelitis optica Soroprevalência do anticorpo NMO-IgG em pacientes brasileiros com neuromielite óptica
by: Tarso Adoni, et al.
Published: (2008-06-01) -
Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica
by: Tianjiao Duan, et al.
Published: (2018-10-01)